TG Therapeutics TGTX Change in Other Current Assets
Change in Other Current Assets at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's change in other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's change in other current assets?
- TG Therapeutics (TGTX) reported change in other current assets of -$10.66M in Q1 2026.
- How has TG Therapeutics's change in other current assets changed year-over-year?
- TG Therapeutics's change in other current assets decreased by 330.4% year-over-year, from $4.63M to -$10.66M.
- What is the long-term trend for TG Therapeutics's change in other current assets?
- Over 2 years (2021 to 2025), TG Therapeutics's change in other current assets has grown at a 123.3% compound annual growth rate (CAGR), from $8.51M to $42.43M.
- What does change in other current assets mean?
- The net change in miscellaneous short-term assets held by the company.
- How do you interpret change in other current assets?
- Significant fluctuations may indicate changes in prepaid service contracts or timing differences in short-term asset recognition.
- How does change in other current assets compare across companies?
- Varies by company accounting policy regarding what is categorized as 'other' current assets.